Karol Watson, M.D., Ph.D., FACC
Co-Director, UCLA Program in Preventive Cardiology
Director, UCLA Barbara Streisand Women's Heart Health Program

Locations:

• Geffen Auditorium (Live) 
• Broadcast to SMH Alfred M-459 and MA 17-64
• Mayo Clinic Health System in Waycross (Video Conference)

Lunch available at Geffen Auditorium and SMH Alfred M-459 on a first come, first serve basis

Learning Objectives:

• Evaluate the safety profile of current and emerging lipid lowering therapies
• Discuss the therapeutic effects of current and emerging lipid lowering therapies
• Discuss the risks of current and emerging lipid lowering therapies

Disclosures:

• Consultant - Astra Zeneca, Daiichi Sankyo, GSK

Off Label/Investigational Uses:

• None

Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Mayo Clinic College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.